Janssen drops biosimilar suit against Samsung

15-11-2017

Janssen drops biosimilar suit against Samsung

ericsphotography / iStockphoto.com

Janssen, a subsidiary of Johnson & Johnson, has dropped a lawsuit against Samsung's biopharmaceutical arm Samsung Bioepis. 


Janssen, Johnson & Johnson, Samsung Bioepis, biosimilar, generic, dismissal, Remicade, biotech

LSIPR